India Still Viable for Drug Innovation, Hisey Says

April 1 (Bloomberg) -- Terry Hisey, vice chairman and U.S. life sciences leader at Deloitte LLP, talks about a ruling by India's Supreme Court denying Novartis AG's request for patent protection for its Gleevec cancer treatment. He speaks with Erik Schatzker and Sara Eisen on Bloomberg Television's "Market Makers." (Source: Bloomberg)

Most Recent Videos

Bareburger CEO Responds to Shake Shack IPO
45:26 - Jan. 30 -- Bareburger CEO Euripides Pelekanos discusses how he will expand the Bareburger brand with Bloomberg's Pimm Fox on "Taking Stock."
  • How Apple Conquered China Market: Bloomberg West (01/30)
  • Should Amazon Spin Off Its Growing Cloud Business?
  • TripAdvisor's Top Pick: Chicago's Langham Hotel